BioXcel Therapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

BioXcel Therapeutics Stock Summary

BioXcel Therapeutics competes with Terns Pharmaceuticals, Amylyx Pharmaceuticals, Acumen Pharmaceuticals, Inozyme Pharma, and X4 Pharmaceuticals. BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut. Bioxcel Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.

BioXcel Therapeutics Key Financial Ratios

BioXcel Therapeutics Key Balance Sheet Accounts

BioXcel Therapeutics Key Income Statement Accounts

BioXcel Therapeutics Key Cash Accounts

BioXcel Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BioXcel Therapeutics's current stock value. Our valuation model uses many indicators to compare BioXcel Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioXcel Therapeutics competition to find correlations between indicators driving BioXcel Therapeutics's intrinsic value. More Info.BioXcel Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . As of now, BioXcel Therapeutics' Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioXcel Therapeutics' earnings, one of the primary drivers of an investment's value.

BioXcel Therapeutics Systematic Risk

Today, most investors in BioXcel Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various BioXcel Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of BioXcel Therapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of BioXcel Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of BioXcel Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of BioXcel Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing BioXcel Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build BioXcel Therapeutics's daily price indicators and compare them against related drivers.

When running BioXcel Therapeutics' price analysis, check to measure BioXcel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioXcel Therapeutics is operating at the current time. Most of BioXcel Therapeutics' value examination focuses on studying past and present price action to predict the probability of BioXcel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioXcel Therapeutics' price. Additionally, you may evaluate how the addition of BioXcel Therapeutics to your portfolios can decrease your overall portfolio volatility.